RGEN - REPLIGEN CORP

QQQ $ 473.14 $ -2.10 (-0.44 %)

DIA $ 417.33 $ 2.44 (0.59 %)

SPY $ 562.48 $ 0.83 (0.15 %)

TLT $ 101.29 $ 0.92 (0.92 %)

GLD $ 238.61 $ -0.02 (-0.01 %)

Previous Close

$ 140

Open

Bid

$ 139.91 x 100

Ask

$ 140.00 x 100

Day's Range

-- - --

52 Week Range

$ 110.45 - $ 211.13

Volume

696,568

Average Volume

Market Cap

7.84B

Beta (5Y Monthly)

$ 1.13

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	07-30-2024	06-30-2024	10-Q
2	05-01-2024	03-31-2024	10-Q
3	02-22-2024	12-31-2023	10-K
4	10-31-2023	09-30-2023	10-Q
5	08-02-2023	06-30-2023	10-Q
6	05-02-2023	03-31-2023	10-Q
7	02-22-2023	12-31-2022	10-K
8	11-01-2022	09-30-2022	10-Q
9	08-02-2022	06-30-2022	10-Q
10	04-27-2022	03-31-2022	10-Q
11	02-17-2022	12-31-2021	10-K
12	10-28-2021	09-30-2021	10-Q
13	07-27-2021	06-30-2021	10-Q
14	05-04-2021	03-31-2021	10-Q
15	02-24-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q
17	07-30-2020	06-30-2020	10-Q
18	05-06-2020	03-31-2020	10-Q
19	02-26-2020	12-31-2019	10-K
20	10-31-2019	09-30-2019	10-Q
21	08-01-2019	06-30-2019	10-Q
22	05-09-2019	03-31-2019	10-Q
23	03-01-2019	12-31-2018	10-K
24	11-01-2018	09-30-2018	10-Q
25	08-02-2018	06-30-2018	10-Q
26	05-08-2018	03-31-2018	10-Q
27	02-22-2018	12-31-2017	10-K
28	11-09-2017	09-30-2017	10-Q
29	08-03-2017	06-30-2017	10-Q
30	05-04-2017	03-31-2017	10-Q
31	02-23-2017	12-31-2016	10-K
32	11-03-2016	09-30-2016	10-Q
33	08-04-2016	06-30-2016	10-Q
34	05-05-2016	03-31-2016	10-Q
35	02-25-2016	12-31-2015	10-K
36	11-05-2015	09-30-2015	10-Q
37	08-06-2015	06-30-2015	10-Q
38	05-08-2015	03-31-2015	10-Q
39	03-17-2015	12-31-2014	10-K
40	11-07-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Wells Fargo Initiates Coverage On Repligen...
08/27/2024 22:03:28

Wells Fargo analyst Brandon Couillard initiates coverage on Repligen (NASDAQ:RGEN) with a Overweight rating and announces Pr...

Repligen shares are trading lower followin...
08/16/2024 18:31:14

wall-street-gains-ground-as-consumer-sentiment-improves-gold-hits-record-highs-boosting-mining-stocks-whats-driving-markets-friday

Wall Street Gains Ground As Consumer Senti...
08/16/2024 17:38:08

Wall Street edged slightly higher on Friday, with major equity indices showing modest gains at midday in New York.

Repligen Corp Has Approached Maravai LifeS...
08/16/2024 15:38:05

- Reuters Citing Sources

Benchmark Reiterates Hold on Repligen
08/05/2024 13:21:12

Benchmark analyst Robert Wasserman reiterates Repligen (NASDAQ:RGEN) with a Hold.

shake-shack-and-lumen-tech-are-among-top-7-mid-cap-stocks-with-max-gains-last-week-july-28-august-3-are-the-others-in-your-portfolio

Shake Shack And Lumen Tech Are Among Top 7...
08/05/2024 00:01:29

Seven mid-cap stocks that performed well last week: LUMN, SHAK, PSN, CWAN, RGEN, FTDR, and NEO. Check if they're in your po...

these-analysts-revise-their-forecasts-on-repligen-following-q2-results

These Analysts Revise Their Forecasts On R...
07/31/2024 18:50:50

JP Morgan Maintains Overweight on Repligen...
07/31/2024 18:23:29

JP Morgan analyst Rachel Vatnsdal maintains Repligen (NASDAQ:RGEN) with a Overweight and raises the price target from $190 t...

UBS Maintains Buy on Repligen, Lowers Pric...
07/31/2024 15:51:39

UBS analyst Elizabeth Garcia maintains Repligen (NASDAQ:RGEN) with a Buy and lowers the price target from $205 to $185.

RBC Capital Reiterates Outperform on Repli...
07/31/2024 15:09:27

RBC Capital analyst Conor McNamara reiterates Repligen (NASDAQ:RGEN) with a Outperform and maintains $190 price target.

why-merck-shares-are-trading-lower-by-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why Merck Shares Are Trading Lower By 10%?...
07/30/2024 17:53:26

repligen-lowers-guidance-on-china-weakness-analyst-expects

Repligen Lowers Guidance On China Weakness...
07/30/2024 16:01:42

Repligen reports Q2 sales of $154.1 million, closely matching the consensus estimate. Adjusted gross margin fell to 49.6% from ...

Stephens & Co. Reiterates Overweight on Re...
07/30/2024 14:50:24

Stephens & Co. analyst Jacob Johnson reiterates Repligen (NASDAQ:RGEN) with a Overweight and maintains $170 price target.

paypal-posts-upbeat-earnings-joins-sprouts-farmers-market-stanley-black--decker-phillips-66-and-other-big-stocks-moving-higher-on-tuesday

PayPal Posts Upbeat Earnings, Joins Sprout...
07/30/2024 14:46:55

Repligen Expects 2024 Revenues Of $620M-$6...
07/30/2024 11:36:03

FINANCIAL GUIDANCE FOR FULL YEAR 2024 All Adjusted figures are non-GAAP Our financial guidance for the full year 2024 is base...

Repligen Q2 2024 Adj. EPS $0.33, Inline, S...
07/30/2024 11:32:07

Repligen To Acquire Tantti Laboratory, Add...
07/29/2024 20:01:04

Enhances Expansion Into New Modality Markets With Scalable Purification Solution; Synergistic With AVIPure And OPUS Columns

Repligen Discovers Unauthorized Access To ...
07/15/2024 20:08:35

this-robinhood-analyst-turns-bullish-here-are-top-5-upgrades-for-wednesday

This Robinhood Analyst Turns Bullish; Here...
06/26/2024 12:44:01

NVIDIA To Rally Around 19%? Here Are 10 To...
06/26/2024 12:12:59